Citadel Advisors - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607900. A total of 4 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q2 2016$7,161,000
+141.0%
375,500
+146.7%
0.01%
+100.0%
Q1 2016$2,971,000
+69.6%
152,200
+235.2%
0.00%
+100.0%
Q4 2015$1,752,000
+1.8%
45,400
-15.3%
0.00%0.0%
Q3 2015$1,721,000
+21.6%
53,600
+15.3%
0.00%
+100.0%
Q2 2015$1,415,000
+215.1%
46,500
+37.6%
0.00%
Q1 2015$449,000
-46.0%
33,800
-41.2%
0.00%
-100.0%
Q4 2014$832,000
-41.5%
57,500
-14.7%
0.00%0.0%
Q3 2014$1,422,000
+69.3%
67,400
+139.0%
0.00%0.0%
Q2 2014$840,000
-57.1%
28,200
-65.4%
0.00%
-50.0%
Q1 2014$1,958,000
+22.5%
81,500
+3.8%
0.00%0.0%
Q4 2013$1,599,000
-46.0%
78,500
+25.2%
0.00%
-60.0%
Q3 2013$2,961,000
+41.2%
62,700
+13.8%
0.01%
+25.0%
Q2 2013$2,097,00055,1000.00%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q3 2014
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 124,000$11,468,0000.01%
JPMORGAN CHASE & CO 200,000$18,496,0000.00%
SIMPLEX TRADING, LLC 32,500$2,543,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of SAREPTA THERAPEUTICS INC shareholders